Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Vicarious Surgical (RBOT) 10K Form and Latest SEC Filings 2026

Vicarious Surgical logo
$0.95 +0.07 (+7.84%)
As of 03:46 PM Eastern

Latest Vicarious Surgical SEC Filings & Recent Activity

Vicarious Surgical (NYSE:RBOT) has submitted 443+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 10-Q submitted on April 30, 2026.

8-K
Vicarious Surgical Files Current Report on Apr. 8, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Vicarious Surgical Files Quarterly Report on Apr. 30, 2026

The 10-Q contains Vicarious Surgical's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Vicarious Surgical SEC Filing History

Browse Vicarious Surgical's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/30/2026 7:30 AM
Vicarious Surgical (1812173) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/08/2026 3:30 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2026 6:01 PM
Innovation Endeavors III LP (1720215) Filed by
Vicarious Surgical (1812173) Subject
Form SCHEDULE 13D/A
03/23/2026 3:30 PM
Vicarious Surgical (1812173) Filer
Form DEF 14A
03/23/2026 8:03 AM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Vicarious Surgical (1812173) Subject
Form 25-NSE
03/13/2026 3:51 PM
Vicarious Surgical (1812173) Filer
Form PRE 14A
03/09/2026 3:16 PM
Vicarious Surgical (1812173) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2026 3:17 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 3:30 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 6:00 AM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2026 1:54 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 1:37 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2026 9:38 AM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2026 9:38 AM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2026 3:53 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 11:15 PM
Vicarious Surgical (1812173) Filer
Form EFFECT
12/22/2025 3:48 PM
Vicarious Surgical (1812173) Filer
Form 424B5
12/17/2025 8:41 AM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Vicarious Surgical (1812173) Subject
Form 25-NSE
12/16/2025 3:15 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2025 3:35 PM
Vicarious Surgical (1812173) Filer
Form S-3
Registration statement under Securities Act of 1933  
12/09/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form 424B3
12/08/2025 11:15 PM
Vicarious Surgical (1812173) Filer
Form EFFECT
12/05/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form PRE 14A
12/04/2025 6:13 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 6:14 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 9:48 AM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 9:48 AM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 6:01 AM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2025 6:27 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 6:28 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 5:28 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2025 5:28 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form D
Notice of Exempt Offering of Securities 
10/08/2025 4:04 PM
Vicarious Surgical (1812173) Filer
Form 424B5
10/08/2025 4:05 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2025 4:06 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2025 12:13 PM
Tang Donald F (1817370) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2025 5:38 AM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2025 3:46 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 3:47 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

09/03/2025 9:25 AM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025 9:25 AM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2025 3:57 PM
Tang Donald F (1817370) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2025 6:53 PM
Tang Donald F (1817370) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2025 6:53 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2025 6:53 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025 9:40 AM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2025 9:40 AM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025 3:16 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025 8:00 PM
FROM STEPHEN (1620137) Reporting
Vicarious Surgical (1812173) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/11/2025 8:00 PM
Ahmad Fuad (1379591) Reporting
Vicarious Surgical (1812173) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/11/2025 8:01 PM
FROM STEPHEN (1620137) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:02 PM
Ho David D (1850976) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:02 PM
HUSS BEVERLY A (1222352) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:02 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:03 PM
Clark Randolph A. (2009653) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:03 PM
Tang Donald F (1817370) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:03 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:04 PM
Ahmad Fuad (1379591) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025 3:30 PM
Vicarious Surgical (1812173) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/30/2025 5:45 AM
Vicarious Surgical (1812173) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025 5:48 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025 5:49 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 11:37 AM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/23/2025 11:37 AM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025 12:44 PM
Mazzola John (1430464) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025 1:16 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025 1:16 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025 10:31 AM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025 10:31 AM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025 12:19 PM
Sachs Adam David (1885593) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 12:19 PM
Khalifa Sammy (1883777) Reporting
Vicarious Surgical (1812173) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Vicarious Surgical SEC Filings - Frequently Asked Questions

Vicarious Surgical (RBOT) has submitted 443+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

Vicarious Surgical's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 10-Q submitted on April 30, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:RBOT) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners